A Pilot Study to Determine How Frequency of Administration Modifies Steady-State Plasma Concentrations of Orally Administered Clozapine

Trial Profile

A Pilot Study to Determine How Frequency of Administration Modifies Steady-State Plasma Concentrations of Orally Administered Clozapine

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 01 Dec 2017

At a glance

  • Drugs Clozapine (Primary)
  • Indications Schizophrenia
  • Focus Pharmacokinetics
  • Acronyms PK-CLZ
  • Most Recent Events

    • 15 Nov 2016 Status changed from recruiting to active, no longer recruiting.
    • 11 Dec 2015 Status changed from not yet recruiting to recruiting ClinicalTrials.gov.
    • 12 Nov 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top